The Impact of Peyronie's Disease on the Patient: Gaps in Our Current Understanding

REFERENCES

• Akin-Olugbade, O., Parker, M., Guhring, P., & Mulhall, J. (2006). Determinants of patient satisfaction following penile prosthesis surgery. Journal of Sexual Medicine, 3, 743–748.
   PubMed Web of Science ®Google Scholar
• Arafa, M., Eid, H., El-Badry, A., Ezz-Eldine, K., & Shamloul, R. (2007). The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction. International Journal of Impotence Research, 19, 213–217.
   PubMed Web of Science ®Google Scholar
• Bacal, V., Rumohr, J., Sturm, R., Lipshultz, L.I., Schumacher, M., & Grober, E.D. (2009). Correlation of degree of penile curvature between patient estimates and objective measures among men with Peyronie's disease. Journal of Sexual Medicine, 6, 862–865.
   PubMed Web of Science ®Google Scholar
• Bella, A.J., Perelman, M.A., Brant, W.O., & Lue, T.F. (2007). Peyronie's disease (CME). Journal of Sexual Medicine, 4, 1527–1538.
   PubMed Web of Science ®Google Scholar
• Casabe, A., Bechara, A., Cheliz, G., De Bonis, W., & Rey, H. (2011). Risk factors of Peyronie's disease. What does our clinical experience show? Journal of Sexual Medicine, 8, 518–523.
   PubMed Web of Science ®Google Scholar
• Cavallini, G., Biagiotti, G., & Lo Giudice, C. (2012). Association between Peyronie's disease and low serum testosterone levels: Detection and therapeutic considerations. Journal of Andrology, 33, 381–388.
   PubMed Web of Science ®Google Scholar
• Cavallini, G., & Caracciolo, S. (2008). Pilot study to determine improvements in subjective penile morphology and personal relationships following a Nesbit plication procedure for men with congenital penile curvature. Asian Journal of Andrology, 10, 512–519.
   PubMed Web of Science ®Google Scholar
• Chitale, S., Morsey, M., Swift, L., & Sethia, K. (2010). Limited shock wave therapy vs sham treatment in men with Peyronie's disease: results of a prospective randomized controlled double-blind trial. BJU International, 106, 1352–1356.
   PubMed Web of Science ®Google Scholar
• Chung, E., Clendinning, E., Lessard, L., & Brock, G. (2010). Five-year follow-up of Peyronie's graft surgery: outcomes and patient satisfaction. Journal of Sexual Medicine, 8, 594–600.
   PubMed Web of Science ®Google Scholar
• Ciftci, H., Savas, M., Gulum, M., Yeni, E., Verit, A., & Topal, U. (2011). Evaluation of sexual function in men with orchialgia. Archives of Sexual Behavior, 40, 631–634.
   PubMed Web of Science ®Google Scholar
• Corona, G., Ricca, V., Bandini, E., Rastrelli, G., Casale, H., Jannini, E.A., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2012). SIEDY Scale 3, a new instrument to detect psychological component in subjects with erectile dysfunction. Journal of Sexual Medicine, 9, 2017–2026.
   PubMed Web of Science ®Google Scholar
• Dang, G., Matern, R., Bivalacqua, T.J., Sikka, S., & Hellstrom, W.J. (2004). Intralesional interferon-α-2B injections for the treatment of Peyronie's disease. Southern Medical Journal, 97, 42–46.
   PubMed Web of Science ®Google Scholar
• Di Stasi, S.M., Giannantoni, A., Stephen, R.L., Capelli, G., Giurioli, A., Jannini, E.A., & Vespasiani, G. (2004). A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. Journal of Urology, 171, 1605–1608.
   PubMed Web of Science ®Google Scholar
• DiBenedetti, D.B., Nguyen, D., Zografos, L., Ziemiecki, R., & Zhou, X. (2011). A population-based study on Peyronie's disease: prevalence and treatment patterns in the United States. Advances in Urology, 2011, 282503.
   PubMedGoogle Scholar
• El-Sakka, A.I. (2006). Prevalence of Peyronie's disease among patients with erectile dysfunction. European Urology, 49, 564–569.
   PubMed Web of Science ®Google Scholar
• El-Sakka, A.I., & Tayeb, K.A. (2005). Peyronie's disease in diabetic patients being screened for erectile dysfunction. Journal of Urology, 174, 1026–1030.
   PubMed Web of Science ®Google Scholar
• Fazili, T., Kouriefs, C., Anjum, F., Masood, S., & Mufti, G.R. (2007). Ten years outcome analysis of corporeal plication for Peyronie's Disease. International Urology and Nephrology, 39, 111–114.
   PubMed Web of Science ®Google Scholar
• Gelbard, M., Dorey, F., & James, K. (1990). The natural history of Peyronie's disease. Journal of Urology, 144, 1376–1379.
   PubMed Web of Science ®Google Scholar
• Gelbard, M., Goldstein, I., Hellstrom, W.J. G., McMahon, C.G., Smith, T., Tursi, J.,  …  Carson, C.C. , III (2013). Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. Journal of Urology, 190, 199–207.
   PubMed Web of Science ®Google Scholar
• Gelbard, M., James, K., Riach, P., & Dorey, F. (1993). Collagenase versus placebo in the treatment of Peyronie's disease: A double-blind study. Journal of Urology, 149, 56–58.
   PubMed Web of Science ®Google Scholar
• Gelbard, M., Lipshultz, L.I., Tursi, J., Smith, T., Kaufman, G., & Levine, L.A. (2012). Phase 2b study of clinical efficacy and safety of collagenase clostridium histolyticum in patients with Peyronie's disease. Journal of Urology, 187, 2268–2274.
   PubMed Web of Science ®Google Scholar
• Gittens, P., Moskovic, D.J., Avila, D., Jr., Chandrashekar, A., Khera, M., & Lipshultz, L.I. (2011). Favorable female sexual function is associated with patient satisfaction after inflatable penile prosthesis implantation. Journal of Sexual Medicine, 8, 1996–2001.
   PubMed Web of Science ®Google Scholar
• Greenfield, J.M., Shah, S.J., & Levine, L.A. (2007). Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial. Journal of Urology, 177, 9729–9775.
   Web of Science ®Google Scholar
• Gur, S., Limin, M., & Hellstrom, W.J. (2011). Current status and new developments in Peyronie's disease: Medical, minimally invasive and surgical treatment options. Expert Opinion on Pharmacotherapy, 12, 931–944.
   PubMed Web of Science ®Google Scholar
• Hauck, E.W. (2006). Editorial Comment:Surgical therapy of Peyronie's disease. European Urology, 50, 248.
   PubMed Web of Science ®Google Scholar
• Hellstrom, W.J. (2009). Medical management of Peyronie's disease. Journal of Andrology, 30, 397–405.
   PubMed Web of Science ®Google Scholar
• Hellstrom, W.J., Feldman, R., Rosen, R.C., Smith, T., Kaufman, G., & Tursi, J. (2013). Bother and distress associated with Peyronie's disease: Validation of the Peyronie's Disease Questionnaire (PDQ). Journal of Urology, 190, 627–634.
   PubMed Web of Science ®Google Scholar
• Hellstrom, W.J., Kendirci, M., Matern, R., Cockerham, Y., Myers, L., Sikka, S.C.,  … Pryor, J.L. (2006). Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon α-2B for minimally invasive treatment for Peyronie's disease. Journal of Urology, 176, 394–398.
   PubMed Web of Science ®Google Scholar
• Jordan, G.H., Carson, C.C., & Lipshultz, L.I. (2014). Minimally invasive treatment of Peyronie's disease: evidence-based progress. BJU International, 114, 16–24.
   PubMed Web of Science ®Google Scholar
• Judge, I.S., & Wisniewski, Z.S. (1997). Intralesional interferon in the treatment of Peyronie's disease: A pilot study. British Journal Urology, 79, 40–42.
   PubMedGoogle Scholar
• Kadioglu, A., Akman, T., Sanli, O., Gurkan, L., Cakan, M., & Celtik, M. (2006). Surgical treatment of Peyronie's disease: A critical analysis. European Urology, 50, 235–248.
   PubMed Web of Science ®Google Scholar
• Kadioglu, A., Tefekli, A., Erol, B., Oktar, T., Tunc, M., & Tellaloglu, S. (2002). A retrospective review of 307 men with Peyronie's disease. Journal of Urology, 168, 1075–1079.
   PubMed Web of Science ®Google Scholar
• Kim, D.H., Lesser, T.F., & Aboseif, S.R. (2008). Subjective patient-reported experiences after surgery for Peyronie's disease: Corporeal plication versus plaque incision with vein graft. Urology, 71, 698–702.
   PubMed Web of Science ®Google Scholar
• La Pera, G., Pescatori, E.S., Calabrese, M., Boffini, A., Colombo, F., Andriani, E.,  … Taggi, F. (2001). Peyronie's disease: Prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50–69 years. European Urology, 40, 525–530.
   PubMed Web of Science ®Google Scholar
• Lindsay, M.B., Schain, D.M., Grambsch, P., Benson, R.C., Beard, C.M., & Kurland, L.T. (1991). The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. Journal of Urology, 146, 1007–1009.
   PubMed Web of Science ®Google Scholar
• Martin-Morales, A., Graziottin, A., Jaoude, G.B., Debruyne, F., Buvat, J., Beneke, M., & Neuser, D. (2011). Improvement in sexual quality of life of the female partner following vardenafil treatment of men with erectile dysfunction: A randomized, double-blind, placebo-controlled study. Journal of Sexual Medicine, 8, 2831–2840.
   PubMed Web of Science ®Google Scholar
• Montorsi, F., Salonia, A., Guazzoni, G., Barbieri, L., Colombo, R., Brausi, M.,  … Pizzini, G. (2000). Transdermal electromotive multi-drug administration for Peyronie's disease: Preliminary results. Journal of Andrology, 21, 85–90.
   PubMed Web of Science ®Google Scholar
• Mulhall, J.P., Alex, B., & Choi, J.M. (2010). Predicting delay in presentation in men with Peyronie's disease. Journal of Sexual Medicine, 7, 2226–2230.
   PubMed Web of Science ®Google Scholar
• Mulhall, J.P., Schiff, J., & Guhring, P. (2006). An analysis of the natural history of Peyronie's disease. Journal of Urology, 175, 2115–2118.
   PubMed Web of Science ®Google Scholar
• Nam, H.J., Park, H.J., & Park, N.C. (2011). Does testosterone deficiency exaggerate the clinical symptoms of Peyronie's disease? International Journal of Urology, 18, 796–800.
   PubMed Web of Science ®Google Scholar
• Nelson, C.J., Diblasio, C., Kendirci, M., Hellstrom, W., Guhring, P., & Mulhall, J.P. (2008). The chronology of depression and distress in men with Peyronie's disease. Journal of Sexual Medicine, 5, 1985–1990.
   PubMed Web of Science ®Google Scholar
• Nelson, C.J., & Mulhall, J.P. (2013). Psychological impact of Peyronie's disease: A review. Journal of Sexual Medicine, 10, 653–660.
   PubMed Web of Science ®Google Scholar
• Paez, A., Mejias, J., Vallejo, J., Romero, I., De, C.M., & Gimeno, F. (2007). Long-term patient satisfaction after surgical correction of penile curvature via tunical plication. International Brazilian Journal of Urology, 33, 502–507.
   PubMedGoogle Scholar
• Palmieri, A., Imbimbo, C., Longo, N., Fusco, F., Verze, P., Mangiapia, F.,  … Mirone, V. (2009). A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease. European Urology, 56, 363–369.
   PubMed Web of Science ®Google Scholar
• Porst, H., Vardi, Y., Akkus, E., Melman, A., Park, N.C., Seftel, A.D.,  … Wyllie, M. (2010). Standards for clinical trials in male sexual dysfunctions. Journal of Sexual Medicine, 7, 414–444.
   PubMed Web of Science ®Google Scholar
• Ralph, D., Gonzalez-Cadavid, N., Mirone, V., Perovic, S., Sohn, M., Usta, M., & Levine, L. (2010). The management of Peyronie's disease: Evidence-based 2010 guidelines. Journal of Sexual Medicine, 7, 2359–2374.
   PubMed Web of Science ®Google Scholar
• Rehman, J., Benet, A., & Melman, A. (1998). Use of intralesional verapamil to dissolve Peyronie's disease plaque: A long-term single-blind study. Urology, 51, 620–626.
   PubMed Web of Science ®Google Scholar
• Rehman, U.S., Rellini, A.H., & Fallis, E. (2011). The importance of sexual self-disclosure to sexual satisfaction and functioning in committed relationships. Journal of Sexual Medicine, 8, 3108–3115.
   PubMed Web of Science ®Google Scholar
• Rhoden, E.L., Riedner, C.E., Fuchs, S., Ribeiro, E.P., & Halmenschlager, G. (2010). A cross-sectional study for the analysis of clinical, sexual and laboratory conditions associated to Peyronie's disease. Journal of Sexual Medicine, 7, 1529–1537.
   PubMed Web of Science ®Google Scholar
• Rosen, R., Catania, J., Lue, T., Althof, S., Henne, J., Hellstrom, W., & Levine, L. (2008). Impact of Peyronie's disease on sexual and psychosocial functioning: Qualitative findings in patients and controls. Journal of Sexual Medicine, 5, 1977–1984.
   PubMed Web of Science ®Google Scholar
• Schwarzer, U., Sommer, F., Klotz, T., Braun, M., Reifenrath, B., & Engelmann, U. (2001). The prevalence of Peyronie's disease: results of a large survey. BJU International, 88, 727–730.
   PubMed Web of Science ®Google Scholar
• Serefoglu, E.C., & Hellstrom, W.J. (2011). Treatment of Peyronie's disease: 2012 update. Current Urology Reports, 12, 444–452.
   PubMedGoogle Scholar
• Shirazi, M., Haghpanah, A.R., Badiee, M., Afrasiabi, M.A., & Haghpanah, S. (2009). Effect of intralesional verapamil for treatment of Peyronie's disease: A randomized single-blind, placebo-controlled study. International Urology and Nephrology, 41, 467–471.
   PubMed Web of Science ®Google Scholar
• Smith, J.F., Breyer, B.N., & Shindel, A.W. (2011). Predictors of sexual bother in a population of male North American medical students. Journal of Sexual Medicine, 8, 3363–3369.
   PubMed Web of Science ®Google Scholar
• Smith, J.F., Walsh, T.J., Conti, S.L., Turek, P., & Lue, T. (2008). Risk factors for emotional and relationship problems in Peyronie's disease. Journal of Sexual Medicine, 5, 2179–2184.
   PubMed Web of Science ®Google Scholar
• Smith, J.F., Walsh, T.J., & Lue, T.F. (2008). Peyronie's disease: A critical appraisal of current diagnosis and treatment. International Journal of Impotence Research, 20, 445–459.
   PubMed Web of Science ®Google Scholar
• Soh, J., Kawauchi, A., Kanemitsu, N., Naya, Y., Ochiai, A., Naitoh, Y.,  …  Miki, T. (2010). Nicardipine vs. saline injection as treatment for Peyronie's disease: A prospective, randomized, single-blind trial. Journal of Sexual Medicine, 7, 3743–3749.
   PubMed Web of Science ®Google Scholar
• Tal, R., Hall, M.S., Alex, B., Choi, J., & Mulhall, J.P. (2012). Peyronie's disease in teenagers. Journal of Sexual Medicine, 9, 302–308.
   PubMed Web of Science ®Google Scholar
• Tan, H.M., Tong, S.F., & Ho, C.C. (2012). Men's health: Sexual dysfunction, physical, and psychological health: Is there a link? Journal of Sexual Medicine, 9, 663–671.
   PubMed Web of Science ®Google Scholar
• Taylor, F.L., & Levine, L.A. (2007). Peyronie's disease. Urologic Clinics of North America, 34, 517–534.
   PubMed Web of Science ®Google Scholar
• Tefekli, A., Kandirali, E., Erol, B., Tunc, M., & Kadioglu, A. (2006). Peyronie's disease: A silent consequence of diabetes mellitus. Asian Journal of Andrology, 8, 75–79.
   PubMed Web of Science ®Google Scholar
• Teloken, C., Rhoden, E.L., Grazziotin, T.M., Ros, C.T., Sogari, P.R., & Souto, C.A. (1999). Tamoxifen versus placebo in the treatment of Peyronie's disease. Journal of Urology, 162, 2003–2005.
   PubMed Web of Science ®Google Scholar
• Usta, M.F., Bivalacqua, T.J., Sanabria, J., Koksal, I.T., Moparty, K., & Hellstrom, W.J. (2003). Patient and partner satisfaction and long-term results after surgical treatment for Peyronie's disease. Urology, 62, 105–109.
   PubMed Web of Science ®Google Scholar
• Weidner, W., Hauck, E.W., & Schnitker, J. (2005). Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: A prospective, placebo-controlled, randomized study. European Urology, 47, 530–535.
   PubMed Web of Science ®Google Scholar
• Yurkanin, J.P., Dean, R., & Wessells, H. (2001). Effect of incision and saphenous vein grafting for Peyronie's disease on penile length and sexual satisfaction. Journal of Urology, 166, 1769–1772.
   PubMed Web of Science ®Google Scholar